EntryPoint Capital’s Ascendis Pharma ASND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-193	Closed	-$29.2K	–	889
2024 Q1	$29.2K	Sell	193 -60	-24%	-$9.07K	0.03%	968
2023 Q4	$31.9K	Buy	+253	New	+$31.9K	0.03%	902